Comprehensive medication management vs medication therapy management
The two terms are used interchangeably across the industry. They describe different things, and the difference decides who is accountable for the outcome.
What is the difference between CMM and MTM?
Medication therapy management is a Medicare Part D program requirement, administered by drug plans, built around an annual comprehensive medication review for beneficiaries who meet targeting criteria. Comprehensive medication management is a standard of clinical practice, delivered inside the care team, covering all medications against all conditions, and continuing through follow-up until the problems found are resolved.
Both involve a pharmacist reviewing a patient's medications. That is where the overlap ends. One is an obligation a plan discharges; the other is a clinical service a practice delivers and is accountable for.
Why are the two terms constantly mixed up?
Because the billing codes carry the wrong name for the way the service is now practiced. CPT 99605, 99606 and 99607 are titled medication therapy management services provided by a pharmacist. Practices delivering full comprehensive medication management often bill through those codes, so the code set says MTM while the service being delivered is CMM.
This is worth stating plainly because it is the source of most vendor confusion. A platform advertising support for comprehensive medication management and listing 99605 to 99607 is not necessarily wrong; it is naming the reimbursement route rather than the service. But it means you cannot tell what a vendor actually delivers from the codes it lists.
The question to ask instead is what happens after the review. If the answer is that a report is produced, that is a review. If the answer is that identified problems are tracked to resolution with the prescribing team, that is management.
What does comprehensive actually add?
Three things: every medication rather than a targeted subset, every active condition rather than one disease, and follow-up rather than a single encounter. A comprehensive medication review under a Part D program is a real and useful service, but it is bounded by the plan's targeting criteria and by the annual cadence.
Comprehensive medication management starts from what the patient is actually taking, which is rarely identical to any single chart's list. Over-the-counter products, supplements, inhalers, and medications prescribed by clinicians who do not share a record all belong in the assessment, because interactions do not respect who wrote the prescription.
It then asks four questions of each medication in turn: is it appropriate for this patient's condition, is it effective, is it safe given the other drugs and comorbidities, and can this patient actually take it as intended. Adherence is treated as a property of the regimen rather than a property of the patient.
Which one should a practice be asking for?
If the goal is to satisfy a plan requirement, medication therapy management is the right frame. If the goal is to change outcomes in a population the practice is accountable for, comprehensive medication management is, because it is the only one of the two that carries an obligation to follow a problem through to resolution.
The distinction becomes concrete in a risk-bearing arrangement. Reviews completed is an activity measure that will look healthy while nothing improves. Problems identified and resolved, regimen simplifications that survive to the next fill, and adherence sustained past the first refill are the measures that track the contract.
For a fee-for-service practice the calculus differs but the structure holds: a service that ends at the report generates a document, and a service that ends at resolution generates a changed regimen.
Related questions
Is CMM just a rebranding of MTM?
No. They emerged from different places. Medication therapy management is a benefit-side construct written into Medicare Part D, with a defined deliverable and defined targeting. Comprehensive medication management is a practice-side standard describing how medication management should be done when a pharmacist is part of the care team.
Can the same encounter be both?
In practice, often yes. A pharmacist delivering comprehensive medication management to a Part D member who meets targeting criteria may satisfy the plan's comprehensive medication review requirement in the same encounter. The service performed is the broader one; the plan credits the narrower obligation.
Which codes apply to CMM?
There is no single dedicated CPT code for comprehensive medication management. CPT 99605, 99606 and 99607 cover pharmacist-delivered medication therapy management in 15-minute increments; Part B coverage is limited and commercial coverage varies. Most programs are funded through time captured under an existing care management program or through a value-based arrangement.
Does MTM require a pharmacist?
Medicare Part D medication therapy management programs are typically delivered by pharmacists, and the comprehensive medication review is the core element. Comprehensive medication management likewise rests on pharmacist clinical judgment, though clinical staff can gather history and support follow-up in both.
Is one better than the other?
They answer different questions and it is not a ranking. A plan needs medication therapy management to meet an obligation to its members. A practice carrying clinical or financial risk needs comprehensive medication management, because a single annual review does not change a regimen.
Code descriptors reflect the AMA CPT code set current as of CY2026; CPT is revised annually and payer coverage varies. Scope-of-practice and collaborative practice authority are set by state law. This is a description of the service, not billing advice for a specific claim.
Talk it through with someone who runs these programs
Praventa operates care management programs with its own clinical team and licenses the same platform to practices running them in-house. Describe your situation and we will tell you which model fits.